SG Americas Securities
ACHV icon

SG Americas Securities’s Achieve Life Sciences ACHV Stock Holding History

SG Americas Securities’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,393
Closed -$28K – 2879
2025
Q1 		$28K Sell
10,393
-9,493
-48% -$29.5K ﹤0.01% 3344
2024
Q4 		$70K Buy
19,886
+8,512
+75% +$38.6K ﹤0.01% 2837
2024
Q3 		$54K Buy
+11,374
New +$52K ﹤0.01% 3232

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SG Americas Securities's ACHV Position: Q2 2025 in Review

SG Americas Securities sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 10,393 shares — an estimated $28K sold.

SG Americas Securities first reported a position in ACHV in Q3 2024 and held it in 3 quarters. The position peaked at $70K in Q4 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • SG Americas Securities reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 10,393 Achieve Life Sciences shares in Q2 2025, an estimated $28K.
  • SG Americas Securities first reported a position in Achieve Life Sciences in Q3 2024 and held it in 3 quarters.
  • SG Americas Securities's Achieve Life Sciences position peaked at $70K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.